HANNAH ERDELY: Open Payments
NPI 1124707815 · MT PLEASANT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 17 payments from 8 companies in 2025. Trend: 2023 $103 · 2024 $340 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| ABBVIE INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| PFIZER INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
Products named: FARXIGA, MOUNJARO, Wegovy, TRELEGY ELLIPTA, UBRELVY, Rybelsus, PREVNAR 20, XIFAXAN.
Industry payments across PA — which companies pay providers there.
